AZ’ Fasenra gets US nod for eosinophilic asthma
admin 15th November 2017 Uncategorised 0AstraZeneca’s biologic Fasenra has picked up its first global approval in the US as a treatment for severe, eosinophilic asthma, a difficult to treat form of the condition.
More: AZ’ Fasenra gets US nod for eosinophilic asthma
Source: News